Geschatte realtime
Cboe BZX
15:55:23 30-04-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
24,8
USD
|
-0,34%
|
|
+1,55%
|
-11,19%
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
3.213
|
3.175
|
3.761
|
4.293
|
4.629
|
4.209
|
-
|
-
|
Bedrijfswaarde
1 |
2.956
|
2.790
|
3.291
|
3.847
|
4.107
|
3.419
|
3.039
|
2.871
|
K/w-verhouding
|
-16,3
x
|
-28,5
x
|
-77,5
x
|
-26,9
x
|
13,2
x
|
12,2
x
|
13,5
x
|
14,1
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
2,74
x
|
3,06
x
|
3,2
x
|
3,86
x
|
2,78
x
|
2,78
x
|
2,76
x
|
2,72
x
|
Bedrijfswaarde/omzet
|
2,52
x
|
2,69
x
|
2,8
x
|
3,46
x
|
2,47
x
|
2,25
x
|
2
x
|
1,85
x
|
Bedrijfswaarde/EBITDA
|
-21,9
x
|
-38,2
x
|
66,7
x
|
-59,7
x
|
8,44
x
|
7,12
x
|
6,42
x
|
5,19
x
|
Bedrijfswaarde/FCF
|
-157
x
|
68,7
x
|
44,7
x
|
-224
x
|
11,6
x
|
8,34
x
|
7,51
x
|
5,76
x
|
FCF Yield
|
-0,64%
|
1,46%
|
2,24%
|
-0,45%
|
8,6%
|
12%
|
13,3%
|
17,4%
|
Price to Book
|
2,97
x
|
2,97
x
|
3,36
x
|
4,11
x
|
3,85
x
|
2,35
x
|
1,97
x
|
1,68
x
|
Aantal aandelen (in duizenden)
|
157.522
|
159.150
|
161.705
|
164.312
|
166.881
|
169.184
|
-
|
-
|
Referentieprijs
2 |
20,40
|
19,95
|
23,26
|
26,13
|
27,74
|
24,88
|
24,88
|
24,88
|
Datum van publicatie
|
13/02/20
|
11/02/21
|
16/02/22
|
16/02/23
|
15/02/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
1.171
|
1.039
|
1.174
|
1.112
|
1.663
|
1.516
|
1.523
|
1.549
|
EBITDA
1 |
-135,1
|
-72,98
|
49,37
|
-64,4
|
486,7
|
480,3
|
473,6
|
553,3
|
Bedrijfsresultaat (EBIT)
1 |
-175,5
|
-112,4
|
-29,29
|
-142,3
|
414,1
|
418
|
411,2
|
449,1
|
Operationele Marge
|
-14,99%
|
-10,82%
|
-2,5%
|
-12,8%
|
24,9%
|
27,57%
|
27%
|
29%
|
Resultaat voor belastingen (EBT)
1 |
-197,1
|
-96,54
|
-39,31
|
-167,3
|
421,5
|
427,7
|
424,2
|
421,1
|
Nettowinst (verlies)
1 |
-196,6
|
-110,9
|
-48,17
|
-158,3
|
355,8
|
352,1
|
331,1
|
328,5
|
Nettomarge
|
-16,79%
|
-10,67%
|
-4,1%
|
-14,24%
|
21,39%
|
23,22%
|
21,74%
|
21,21%
|
WPA
2 |
-1,250
|
-0,7000
|
-0,3000
|
-0,9700
|
2,100
|
2,040
|
1,847
|
1,762
|
Free Cash Flow
1 |
-18,86
|
40,62
|
73,7
|
-17,21
|
353,3
|
410
|
404,8
|
498,6
|
FCF-marge
|
-1,61%
|
3,91%
|
6,28%
|
-1,55%
|
21,24%
|
27,04%
|
26,58%
|
32,19%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
149,28%
|
-
|
72,59%
|
85,37%
|
85,47%
|
90,11%
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
99,31%
|
116,46%
|
122,29%
|
151,79%
|
Dividend per aandeel
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
13/02/20
|
11/02/21
|
16/02/22
|
16/02/23
|
15/02/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Omzet
1 |
294,1
|
324,5
|
278,5
|
276,2
|
252,4
|
304,7
|
287,6
|
617,4
|
380,9
|
377,5
|
360,3
|
391,1
|
384,3
|
375,8
|
350,6
|
EBITDA
1 |
-10,04
|
23,53
|
-7,388
|
-25,39
|
-51,48
|
-0,907
|
-38,69
|
66,97
|
78,09
|
72,85
|
113,7
|
134,6
|
112,8
|
102,4
|
-
|
Bedrijfsresultaat (EBIT)
1 |
-19,66
|
2,383
|
-26,58
|
-34,46
|
-60,64
|
-20,58
|
-47,49
|
239,2
|
43,85
|
54,63
|
90,09
|
119,7
|
112,8
|
105,9
|
104,4
|
Operationele Marge
|
-6,68%
|
0,73%
|
-9,54%
|
-12,47%
|
-24,03%
|
-6,76%
|
-16,51%
|
38,74%
|
11,51%
|
14,47%
|
25,01%
|
30,59%
|
29,36%
|
28,19%
|
29,78%
|
Resultaat voor belastingen (EBT)
1 |
-26,54
|
0,227
|
-45
|
-33,25
|
-67,37
|
-21,69
|
-47,86
|
239,8
|
47,36
|
58,32
|
88,93
|
110,8
|
119,6
|
120,3
|
-
|
Nettowinst (verlies)
1 |
-28,99
|
0,873
|
-35,9
|
-30,14
|
-63,97
|
-28,25
|
-41,84
|
237,1
|
47,76
|
112,8
|
74,94
|
92,92
|
89,94
|
85,52
|
-
|
Nettomarge
|
-9,86%
|
0,27%
|
-12,89%
|
-10,91%
|
-25,35%
|
-9,27%
|
-14,55%
|
38,4%
|
12,54%
|
29,88%
|
20,8%
|
23,76%
|
23,41%
|
22,76%
|
-
|
WPA
2 |
-0,1800
|
0,0100
|
-0,2200
|
-0,1800
|
-0,3900
|
-0,1700
|
-0,2500
|
1,380
|
0,2800
|
0,6600
|
0,4401
|
0,5435
|
0,5257
|
0,4955
|
-
|
Dividend per aandeel
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
27/10/21
|
16/02/22
|
27/04/22
|
27/07/22
|
2/11/22
|
16/02/23
|
26/04/23
|
26/07/23
|
25/10/23
|
15/02/24
|
-
|
-
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
258
|
385
|
470
|
447
|
523
|
791
|
1.170
|
1.338
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-18,9
|
40,6
|
73,7
|
-17,2
|
353
|
410
|
405
|
499
|
ROE (netto-inkomsten/eigen vermogen)
|
9,94%
|
6,38%
|
11,8%
|
5,37%
|
21,7%
|
27,6%
|
20,6%
|
18,1%
|
ROA (netto-inkomsten/totale activa)
|
6,18%
|
3,66%
|
6,5%
|
2,9%
|
11,9%
|
20,2%
|
17,3%
|
14,5%
|
Totale activa
1 |
-3.181
|
-3.032
|
-741,4
|
-5.455
|
2.993
|
1.745
|
1.909
|
2.262
|
Nettoactief per aandeel
2 |
6,880
|
6,720
|
6,910
|
6,350
|
7,200
|
10,60
|
12,60
|
14,80
|
Cashflow per aandeel
2 |
0,4600
|
0,5200
|
0,6300
|
0,1300
|
2,360
|
3,080
|
2,870
|
-
|
Capex
1 |
90,9
|
42,2
|
28
|
38,3
|
48
|
40,7
|
38,7
|
38,2
|
Capex/omzet
|
7,77%
|
4,06%
|
2,39%
|
3,44%
|
2,89%
|
2,68%
|
2,54%
|
2,47%
|
Datum van publicatie
|
13/02/20
|
11/02/21
|
16/02/22
|
16/02/23
|
15/02/24
|
-
|
-
|
-
|
Gemiddeld advies Accumuleren Laatste slotkoers
24,88
USD Gemiddelde koersdoel
35,25
USD Spread / Gemiddelde doel +41,68% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| -11,19% | 4,21 mld. | | +0,96% | 42,86 mld. | | +10,85% | 42,74 mld. | | +44,42% | 41,36 mld. | | -8,83% | 27,68 mld. | | +7,07% | 25,15 mld. | | -23,95% | 18,63 mld. | | +29,37% | 12,37 mld. | | -2,15% | 11,92 mld. | | +7,10% | 11,21 mld. |
Biotechnologie & Medisch Onderzoek - Andere
|